# Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus

Study · id `cardio:ct-nct05825573` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05825573](<https://clinicaltrials.gov/study/NCT05825573>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05825573

Browse, organ or system: Heart; Brain  
Browse, condition area: Coronary and vascular disease; Stroke; Heart failure; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 340 participants.

## Technical summary

Registry record NCT05825573. Randomized; no masking; primary purpose treatment. Start 2023-05-15 (actual); primary completion 2025-02-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 340 participants (planned count; ClinicalTrials.gov record NCT05825573, source copy `cardio:ctgov-nct05825573-2026-02-17`, retrieved 2026-10-26)
- Started: 2023-05-15 (actual) (ClinicalTrials.gov record NCT05825573, source copy `cardio:ctgov-nct05825573-2026-02-17`, retrieved 2026-10-26)
- Primary completion: 2025-02-05 (actual) (ClinicalTrials.gov record NCT05825573, source copy `cardio:ctgov-nct05825573-2026-02-17`, retrieved 2026-10-26)
- Completion: 2026-02 (anticipated) (ClinicalTrials.gov record NCT05825573, source copy `cardio:ctgov-nct05825573-2026-02-17`, retrieved 2026-10-26)
- Countries: France; Réunion (ClinicalTrials.gov record NCT05825573, source copy `cardio:ctgov-nct05825573-2026-02-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05825573-2026-02-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus
- Acronym: ARGONAUT
- Condition: Intracardiac Thrombus
- Condition: STEMI
- Condition: Heart Failure
- Intervention (Drug): Vitamin K antagonist
- Intervention (Drug): Direct oral anticoagulant
- Lead sponsor: Centre Hospitalier Universitaire de Nīmes
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Centre Hospitalier Universitaire de Nīmes (`cardio:org-centre-hospitalier-universitaire-de-nimes`)

## Provenance

Content hash: 6a769f042b76088f287690e66c8a65286c6dc1cc54f0a3fa171371b9a4d9c77c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
